Clinical evaluation of the 1940 nm non-ablative fractional diode laser for skin resurfacing and treatment of benign pigmented lesions

The 1940 nm non-ablative fractional laser is FDA-cleared for treatment of benign pigmented lesions.

Available on the Nordlys® system, you can now offer patients a way to enjoy smoother skin and get clearance of their dark spots in a single treatment!

Read about the immediate and glowing 1940 nm laser treatment results for both epidermal skin resurfacing and pigmentation. Download the clinical results white paper and learn how you can expand your practice offerings with targeted epidermal treatments, the latest in non-ablative technology.

*Nordlys Systems, 510(k) clearance (K212492), December 2021.
Nordlys Health Canada Medical Device License (108788), January 2023.